Accueil
Rx
SP

Sanofi-Synthelabo Pharmaceuticals

308
18
3
4.1(65)

À Propos de l'Entreprise

  • Raison sociale: Sanofi-Synthelabo Pharmaceuticals
  • Nom international: Sanofi-Synthélabo, merged into Sanofi-Aventis (2004) and now Sanofi, Paris
  • Marque / Nom commercial: Sanofi
  • Pays d'enregistrement: France
  • Adresse: 46 Avenue de la Grande Armée, 75017 Paris, France • Île-de-France
  • Année de création: 1999
Description:

French pharmaceutical company created in 1999 from the merger of Sanofi with Synthélabo, the drug business of L'Oréal, with medicines for thrombosis, cardiovascular disease, epilepsy and sleep. It bought Aventis in 2004 to form Sanofi-Aventis, which took the name Sanofi in 2011 and continues as one of the largest pharmaceutical companies in the world.

Activités Commerciales

Formes Pharmaceutiques Finies

Fabricant

Services Biopharmaceutiques

Institut de Recherche

Produits Biopharmaceutiques

Entreprise de Biotechnologie / Biopharmaceutique
Filtres :
Trier par :

    Aucun commentaire disponible.

Sanofi-Synthelabo Pharmaceuticals | PharmaCountry